BioCatalyst

Apalutamide, Androgen Deprivation Therapy (ADT) — catalyst calendar

1 verified catalyst event(s) referencing Apalutamide, Androgen Deprivation Therapy (ADT), each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-01
in 27d
ESTIMATED
 READOUT
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Adva
Phase 3 · Prostatic Neoplasms
 Janssen Research & Development, LL Apalutamide, Androgen Deprivation Therap ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.